KTOV - Ties With Merck Could Explain Kitov's Market Interest

Kitov Pharma Ltd. (KTOV) has recently become one of the most commented stocks on Twitter. The company is a clinical-stage pharmaceutical company having ties with Merck (MRK) and venture capital firms, like Arkin Holdings, Orbimed, and Pontifax. I cannot really explain why the market, at this point in time, is that interested in KTOV. The market opportunity is larger than $11 billion. However, the company will need many years to reach the status of FDA approval and it may have to raise capital several times. It could represent a buying opportunity, but as

Read more ...